Just spoke to the company, Pfizer continues to attend all regulatory meetings for HCV program , hardly a company that has lost interest, all Sandwich programs were terminated the HCV was the very last to be let go, almost a year after everything else, dont be shocked if Pfizer comes back after phase 2 results, equal valuation to Mesoblast is 45 dollars a share.
